You are here

Downing’s HD Research Garnering National Acclaim

Nancy Downing

Professor Nancy Downing, PhD, RN, SANE-A, has a long-standing interest in genomics, including the analysis of how genetic pathways influence pathology and health. Her research focuses on improving quality of life for people affected by Huntington disease (HD) and other conditions with a major genetic contribution.

Dr. Downing is being recognized as a Shoulson Scholar by the Huntington Study Group (HSG). Created in honor of HSG’s founder, Dr. Ira Shoulson, the Shoulson Scholar Fund recognizes outstanding junior investigators with a future of promising research in Huntington disease. 

Specifically, Downing is being recognized for her involvement as a researcher in a multi-site multi-disciplinary study called PREDICT-HD. The major goal of this study is to find sensitive markers of change in people affected by the gene mutation that causes HD that can be used for outcome measures in clinical trials and in the clinical setting to determine whether treatments are effective.

“Because HD is a rare disease, successful research efforts require a great deal of collaboration with other scientists,” said Downing. “Being named an Ira Shoulson Scholar really gives me a seat at the table with top HD researchers from around the world.”

Dr. Downing’s research with the PREDICT-HD study will be presented at HSG’s upcoming conference October 21-24 in Tampa Bay, Fla.

“Attending the annual meeting will give me the opportunity to network with some of the most renowned HD researchers from across the globe. I’ll also be presenting at the conference, which will help raise the profile of my research while expanding collaborative opportunities in this field,” she added.

# # #

The Huntington Study Group (HSG) is a world leader in facilitating high-quality clinical research trials and studies in Huntington disease (HD). HSG has the first and largest HD clinical research network with more than 400 active and compassionate investigators, coordinators, scientists and HD experts at more than 100 HSG Credentialed Research Sites across the globe dedicated to seeking treatments that make a difference and improving the quality of life and outcomes for families affected by HD. Learn more at

Posted On: 
Sep 1st, 2015